The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Reading miRNAs for Clinical Meaning
Single miRNAs Don’t Say Much, but They May Become Eloquent Biomarkers if We Take Their Testimony in Context
Sorting Out the CRISPR Patent Case
Sounds of Science Podcast
For full access to this article login to GEN Select now.
Cell-Line Development: Where Nature Meets Nurture
From our February 1 issue.
- While nurture (process optimization, media, and feed strategies) ultimately trumps nature (cell line) for maximizing protein titer, the importance of starting out with the right cell line cannot be overstated. Volumetric productivity, product quality, and the ability to meet timelines are three factors that bioprocessors balance at different stages ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.